TY  - JOUR
AU  - Rubio-Viqueira, Belen
AU  - Tarruella, Margarita Majem
AU  - Lazaro, Martin
AU  - Estevez, Sergio Vazquez
AU  - Cordoba-Ortega, Juan Felipe
AU  - Maiques, Inmaculada Maestu
AU  - Gonzalez, Jorge Garcia
AU  - Cordellat, Ana Blasco
AU  - Valdivia-Bautista, Javier
AU  - Arenas, Carmen Gonzalez
AU  - Sanchez Torres, Jose Miguel
PY  - 2021
DO  - 10.2217/lmt-2021-0008
SN  - 1758-1966
UR  - https://hdl.handle.net/10668/26310
T2  - Lung cancer management
AB  - Aim: To describe the clinical management and PD-L1 testing of patients with newly diagnosed stage IV non-small cell lung cancer (NSCLC) without driver mutations in Spain. Methods: Multicenter, retrospective study. Results: Among 297 evaluated...
LA  - en
PB  - Future medicine ltd
KW  - advanced
KW  - first-line treatment
KW  - immunotherapy
KW  - metastatic
KW  - NSCLC
KW  - PD-L1 expression
KW  - Open-label
KW  - Pembrolizumab
KW  - Chemotherapy
KW  - Multicenter
KW  - Therapy
KW  - Phase-3
TI  - PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study
TY  - research article
VL  - 10
ER  -